Micro‐Engineered Organoid‐on‐a‐Chip Based on Mesenchymal Stromal Cells to Predict Immunotherapy Responses of HCC Patients

Hepatocellular carcinoma (HCC) is one of the most lethal cancers worldwide. Patient‐derived organoid (PDO) has great potential in precision oncology, but low success rate, time‐consuming culture, and lack of tumor microenvironment (TME) limit its application. Mesenchymal stromal cells (MSC) accumula...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Zhengyu, Lin, Zhun, Wu, Chenglin, Tan, Jizhou, Zhang, Jie, Peng, Yanwen, Zhang, Kunsong, Li, Jiaping, Wu, Minhao, Zhang, Yuanqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520686/
https://www.ncbi.nlm.nih.gov/pubmed/37485650
http://dx.doi.org/10.1002/advs.202302640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520686/
https://www.ncbi.nlm.nih.gov/pubmed/37485650
http://dx.doi.org/10.1002/advs.202302640

Ejemplares similares